Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
06/11/2025
After the Central Bank of Malaysia maintained the interest rate at 2.75%, the Malaysian Ringgit remained stable, rising by 0.2% to 4.1820 ringgit against the US dollar.
Latest
1 m ago
Hong Kong Stock Exchange: The average daily turnover in October 2025 was 274.9 billion yuan, up 8% from 255 billion yuan in the same period last year. The average daily turnover for the first ten months of 2025 was 258.2 billion yuan, up 102% from 127.8 billion yuan in the same period last year.
1 m ago
Duofuduo (002407.SZ) subsidiary will deliver boron isotope products to China General Nuclear Power Corporation
1 m ago
Standard Chartered Group (02888.HK) spent approximately 765.75 million pounds on November 5 to repurchase about 48.1 million shares.
1 m ago
An official from the Italian National Institute of Statistics stated that Italy has not fallen into recession, as current data does not show a negative growth in the country's GDP in the fourth quarter.
2 m ago
Novartis Pharmaceuticals (NVS.US) first radioligand therapy drug Lutathera receives dual indications simultaneously.
See all latest